Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiovascular Research in EMbarazo and MAternity (EMMA). Study on Heart Rate Variability and Hemodynamic Adaptations During Pregnancy and Postpartum.

NCT07376616 is registered in ClinicalTrials.gov with Fundacin Biomedica Galicia Sur as lead sponsor.

NCT NCT07376616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07376616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiovascular Research in EMbarazo and MAternity (EMMA). Study on Heart Rate Variability and Hemodynamic Adaptations During Pregnancy and Postpartum.
Lead sponsor
Fundacin Biomedica Galicia Sur
Phase
Observational
Overall status
Recruiting
Start date
May 19, 2025
Completion date
December 15, 2027
Enrollment
242 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart rate variation (hrv), hemodynamics, pregnancy related